(macitentan)
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Last Updated: 12/17/2024
The stability of OPSUMIT film-coated tablets in blister packs was investigated at 40°C and 75% relative humidity for up to 6 months.1
In another study, the stability of OPSUMIT tablets in blister packs was investigated at 25°C and 60% relative humidity as well as 30°C and 75% relative humidity, for up to 24 months.1 Over this time period, no significant changes in the appearance, color, average mass, water content, or dissolution profile occurred.
The stability of OPSUMIT film-coated tablets when opened daily for 20 minutes in Climatic Zone IV (hot humid/tropical zone as per the ICH stability zones i.e. 30°C and 75% humidity),2
The stability of OPSUMIT tablets stored in high-density polyethylene (HDPE) bottles was tested in a temperature cycling study.1 OPSUMIT tablets stored in HDPE bottles were subjected to -20°C for 2 days, followed by 60°C for 2 days; this temperature cycle was repeated 3 times. Appearance, dissolution and assay and related substance testing was performed at the beginning and end of each cycle. The results of the study suggest that the product specification of OPSUMIT, after being stored in HDPE bottles and subjected to 3 two-day freeze (-20°C) to two-day thaw (60°C) cycles, is preserved.
A literature search of MEDLINE®
1 | Data on File. Macitentan. Formulation development and temperature cycling stability report. Janssen Scientific Affairs, LLC; 2020. |
2 | Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. WHO Technical Report Series, No. 953, Annex 2. 2024-12-13. http://bit.ly/3Bvqrtg |